腹主动脉腔内修复手术质量评价指标体系的中国专家共识

2018-07-30 国家心血管病专业质控中心专家委员会血管外科专家工作组 中国普通外科杂志.2018.27(6):669-673.

近年来,中国腹主动脉腔内修复手术(EVAR)的实施规模快速扩增,实施单位由早年的区域中心医院扩展到部分省市的中型医院,与医疗水平均一性差、医疗资源消耗不合理相关的质量问题逐渐显现。如何评价和改善医疗质量、提高国家医疗卫生支出的利用效率这一重大课题,引起了国家卫生主管部门高度重视。经国家心血管病专业质控中心专家委员会血管外科专家工作组全体专家讨论,拟定了术前CTA 检查、术中血压监测和控制性血压调节

中文标题:

腹主动脉腔内修复手术质量评价指标体系的中国专家共识

发布日期:

2018-07-30

简要介绍:

近年来,中国腹主动脉腔内修复手术(EVAR)的实施规模快速扩增,实施单位由早年的区域中心医院扩展到部分省市的中型医院,与医疗水平均一性差、医疗资源消耗不合理相关的质量问题逐渐显现。如何评价和改善医疗质量、提高国家医疗卫生支出的利用效率这一重大课题,引起了国家卫生主管部门高度重视。经国家心血管病专业质控中心专家委员会血管外科专家工作组全体专家讨论,拟定了术前CTA 检查、术中血压监测和控制性血压调节、术中覆膜支架放大使用率、术后CTA 复查率等4 项过程指标,风险校正术后30 d 病死率、风险校正术后30 d 全因再入院率、中转开放手术发生率、入路血管再次干预发生率、主髂动脉再次干预率、手术时间、ICU 停留时间、机械通气时间延长发生率、术后肾功能不全发生率、患者术后住院天数等10 项结局指标,以及注册登记参与率这一项结构指标,以期通过上述关键指标的考核、推广,提高不同地域、不同级别医院EVAR 手术质量的均一性。 

拓展指南:腹主动脉相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=腹主动脉腔内修复手术质量评价指标体系的中国专家共识)] GetToolGuiderByIdResponse(projectId=1, id=b518d1c001625890, title=腹主动脉腔内修复手术质量评价指标体系的中国专家共识, enTitle=, guiderFrom=中国普通外科杂志.2018.27(6):669-673., authorId=null, author=, summary=近年来,中国腹主动脉腔内修复手术(EVAR)的实施规模快速扩增,实施单位由早年的区域中心医院扩展到部分省市的中型医院,与医疗水平均一性差、医疗资源消耗不合理相关的质量问题逐渐显现。如何评价和改善医疗质量、提高国家医疗卫生支出的利用效率这一重大课题,引起了国家卫生主管部门高度重视。经国家心血管病专业质控中心专家委员会血管外科专家工作组全体专家讨论,拟定了术前CTA 检查、术中血压监测和控制性血压调节, cover=, journalId=null, articlesId=null, associationId=1693, associationName=国家心血管病专业质控中心专家委员会血管外科专家工作组, associationIntro=, copyright=0, guiderPublishedTime=Mon Jul 30 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>近年来,中国腹主动脉腔内修复手术(EVAR)的实施规模快速扩增,实施单位由早年的区域中心医院扩展到部分省市的中型医院,与医疗水平均一性差、医疗资源消耗不合理相关的质量问题逐渐显现。如何评价和改善医疗质量、提高国家医疗卫生支出的利用效率这一重大课题,引起了国家卫生主管部门高度重视。经国家心血管病专业质控中心专家委员会血管外科专家工作组全体专家讨论,拟定了术前CTA 检查、术中血压监测和控制性血压调节、术中覆膜支架放大使用率、术后CTA 复查率等4 项过程指标,风险校正术后30 d 病死率、风险校正术后30 d 全因再入院率、中转开放手术发生率、入路血管再次干预发生率、主髂动脉再次干预率、手术时间、ICU 停留时间、机械通气时间延长发生率、术后肾功能不全发生率、患者术后住院天数等10 项结局指标,以及注册登记参与率这一项结构指标,以期通过上述关键指标的考核、推广,提高不同地域、不同级别医院EVAR 手术质量的均一性。 </div> <div><br> </div>拓展指南:<strong>与<font color="red">腹主动脉</font>相关指南:</strong><br><ul><li><a title="2017 SVS实践指南:腹主动脉瘤患者的护理" target="_blank" href="http://www.medsci.cn/guideline/show_article.do?id=f24a71c0015362a1">2017 SVS实践指南:腹主动脉瘤患者的护理</a></li> <li><a title="2017 CTFPHC建议:基层医疗中腹主动脉瘤的筛查" target="_blank" href="http://www.medsci.cn/guideline/show_article.do?id=4fda41c001a96268">2017 CTFPHC建议:基层医疗中腹主动脉瘤的筛查</a></li> <li><a title="2017 WVS指南:腹主动脉瘤破裂患者的转诊" target="_blank" href="http://www.medsci.cn/guideline/show_article.do?id=bfdcf1c0013e824f">2017 WVS指南:腹主动脉瘤破裂患者的转诊</a></li> <li><a title="2014 USPSTF 腹主动脉瘤筛查推荐声明" target="_blank" href="http://www.medsci.cn/guideline/show_article.do?id=391a51c001083eb9">2014 USPSTF 腹主动脉瘤筛查推荐声明</a></li> <li><a title="2013 CIRSE指南:腹主动脉与髂动脉疾病的腔内治疗" target="_blank" href="http://www.medsci.cn/guideline/show_article.do?id=ceee61c00103251a">2013 CIRSE指南:腹主动脉与髂动脉疾病的腔内治疗</a></li> 更多信息请点击:<a target="_blank" href="http://www.medsci.cn/guideline/list.do?q=%E8%85%B9%E4%B8%BB%E5%8A%A8%E8%84%89">有关腹主动脉更多指南</a></ul>, tagList=[TagDto(tagId=78993, tagName=腹主动脉腔内修复手术), TagDto(tagId=78994, tagName=质量评价指标体系)], categoryList=[CategoryDto(categoryId=23, categoryName=普通外科, tenant=100), CategoryDto(categoryId=92, categoryName=血管外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5800, appHits=144, showAppHits=0, pcHits=4577, showPcHits=1406, likes=125, shares=2, comments=6, approvalStatus=1, publishedTime=Fri Aug 10 21:36:51 CST 2018, publishedTimeString=2018-07-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Fri Aug 10 21:36:51 CST 2018, updatedBy=null, updatedName=null, updatedTime=Fri Jan 05 11:22:23 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=腹主动脉腔内修复手术质量评价指标体系的中国专家共识)])
腹主动脉腔内修复手术质量评价指标体系的中国专家共识
下载请点击:
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1184019, encodeId=7a56118401901, content=学习受教了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210424/75ca38f652414914af9cbfb5b446886f/ea6e0bf538564d608b3eecda251c149e.jpg, createdBy=58765422551, createdName=ms5000001465822468, createdTime=Thu Jan 13 20:57:13 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364126, encodeId=10e9364126e5, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d98a2577012, createdName=Sean Xie, createdTime=Thu Apr 04 22:19:26 CST 2019, time=2019-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=337829, encodeId=535133e8292a, content=学习了,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Aug 11 06:58:42 CST 2018, time=2018-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=337784, encodeId=10b033e78434, content=不错的文章值得拥有哦哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Fri Aug 10 23:49:13 CST 2018, time=2018-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=337772, encodeId=f57d33e7726d, content=学习了,谢谢分享。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Fri Aug 10 22:54:42 CST 2018, time=2018-08-10, status=1, ipAttribution=)]
    2022-01-13 ms5000001465822468

    学习受教了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1184019, encodeId=7a56118401901, content=学习受教了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210424/75ca38f652414914af9cbfb5b446886f/ea6e0bf538564d608b3eecda251c149e.jpg, createdBy=58765422551, createdName=ms5000001465822468, createdTime=Thu Jan 13 20:57:13 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364126, encodeId=10e9364126e5, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d98a2577012, createdName=Sean Xie, createdTime=Thu Apr 04 22:19:26 CST 2019, time=2019-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=337829, encodeId=535133e8292a, content=学习了,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Aug 11 06:58:42 CST 2018, time=2018-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=337784, encodeId=10b033e78434, content=不错的文章值得拥有哦哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Fri Aug 10 23:49:13 CST 2018, time=2018-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=337772, encodeId=f57d33e7726d, content=学习了,谢谢分享。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Fri Aug 10 22:54:42 CST 2018, time=2018-08-10, status=1, ipAttribution=)]
    2019-04-04 Sean Xie

    不错

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1184019, encodeId=7a56118401901, content=学习受教了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210424/75ca38f652414914af9cbfb5b446886f/ea6e0bf538564d608b3eecda251c149e.jpg, createdBy=58765422551, createdName=ms5000001465822468, createdTime=Thu Jan 13 20:57:13 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364126, encodeId=10e9364126e5, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d98a2577012, createdName=Sean Xie, createdTime=Thu Apr 04 22:19:26 CST 2019, time=2019-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=337829, encodeId=535133e8292a, content=学习了,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Aug 11 06:58:42 CST 2018, time=2018-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=337784, encodeId=10b033e78434, content=不错的文章值得拥有哦哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Fri Aug 10 23:49:13 CST 2018, time=2018-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=337772, encodeId=f57d33e7726d, content=学习了,谢谢分享。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Fri Aug 10 22:54:42 CST 2018, time=2018-08-10, status=1, ipAttribution=)]
    2018-08-11 1209e435m98(暂无昵称)

    学习了,谢谢分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1184019, encodeId=7a56118401901, content=学习受教了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210424/75ca38f652414914af9cbfb5b446886f/ea6e0bf538564d608b3eecda251c149e.jpg, createdBy=58765422551, createdName=ms5000001465822468, createdTime=Thu Jan 13 20:57:13 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364126, encodeId=10e9364126e5, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d98a2577012, createdName=Sean Xie, createdTime=Thu Apr 04 22:19:26 CST 2019, time=2019-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=337829, encodeId=535133e8292a, content=学习了,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Aug 11 06:58:42 CST 2018, time=2018-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=337784, encodeId=10b033e78434, content=不错的文章值得拥有哦哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Fri Aug 10 23:49:13 CST 2018, time=2018-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=337772, encodeId=f57d33e7726d, content=学习了,谢谢分享。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Fri Aug 10 22:54:42 CST 2018, time=2018-08-10, status=1, ipAttribution=)]
    2018-08-10 1e1b8538m79(暂无匿称)

    不错的文章值得拥有哦哦

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1184019, encodeId=7a56118401901, content=学习受教了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210424/75ca38f652414914af9cbfb5b446886f/ea6e0bf538564d608b3eecda251c149e.jpg, createdBy=58765422551, createdName=ms5000001465822468, createdTime=Thu Jan 13 20:57:13 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=364126, encodeId=10e9364126e5, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d98a2577012, createdName=Sean Xie, createdTime=Thu Apr 04 22:19:26 CST 2019, time=2019-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=337829, encodeId=535133e8292a, content=学习了,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Aug 11 06:58:42 CST 2018, time=2018-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=337784, encodeId=10b033e78434, content=不错的文章值得拥有哦哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Fri Aug 10 23:49:13 CST 2018, time=2018-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=337772, encodeId=f57d33e7726d, content=学习了,谢谢分享。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Fri Aug 10 22:54:42 CST 2018, time=2018-08-10, status=1, ipAttribution=)]
    2018-08-10 惠映实验室

    学习了,谢谢分享。

    0